This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Pharmaceutical Market: China

Projections 22

Current State 23

REGULATORY AFFAIRS 24

NATIONAL AUTHORITY 24

Department of Drug Registration24

REGULATORY DEVELOPMENTS 24

SFDA Starts Overseas Factory Inspections 24

Revised GMP Regulations 25

Revised Antibiotic Regulations 25

MARKETING REGISTRATION 25

Department of Drug Safety & Inspection 26

Department of Drug Market Compliance 26

Drug Classification 27

Regulatory Legislation27

2001 DAL Amendments 27

Drug Import Regulation 28

GMP Regulations 28

Drug Approval Process 28

Clinical Trials28

Quality Tests29

Certification 29

PACKAGING 29

POST-MARKETING SURVEILLANCE 30

Revoked Licences30

Bribery Cases 30

PROMOTION 30

Advertising 30

PRICING & REIMBURSEMENT 31

PRICING 31

National Pricing31

REIMBURSEMENT 32

DISTRIBUTION CHANNELS 34

DRUG WHOLESALING 34

Selected Wholesalers35

Alliance Boots35

China Medical System 35

Chindex 35

First China Pharmaceutical Group 36

Global Pharm Holdings Group 37

Guangzhou Pharmaceutical 37

Hutchison China MediTech 38

Jointown Pharmaceutical Group 38

Nanjing Pharmaceutical 39

Shanghai Pharmaceuticals 39

Sinopharm40

DRUG RETAILING42

Selected Pharmacy Chains42

China BCT Pharmacy Group 42

ShenZhen Nepstar 42

MARKET ANALYSIS 43

SIZE 43

Projections 43

Historical Figures 45

Current Structure 46

PRODUCT DEVELOPMENT 48

12th Five-Year Plan 2011-2015 48

Mega New Drug Development Programme 48

SFDA R&D Initiatives 48

Beijing Economic-Technological Development Area49

Zhangjiang Hi-Tech Park 49

MANUFACTURING 50

China to Turn Five Companies into International Producers 52

TRADE52

Exports 52

Imports 55

Balance of Trade 59

COMPETITION 61

TRADE ASSOCIATIONS 61

CAPC61

CCCMHPIE 61

CPIA 61

RDPAC 62

TRADE FAIRS 63

Interphex China63

PharmChina 63

COMPANY INTELLIGENCE 64

Foreign Manufacturers64

Astellas Pharma64

AstraZeneca64

Boehringer Ingelheim 65

Bristol-Myers Squibb66

Daiichi Sankyo 66

Dainippon Sumitomo Pharma 67

Dragon Pharmaceuticals 67

Eisai68

Eli Lilly 68

GlaxoSmithKline 69

Johnson & Johnson69

Merck KGaA 70

Merck Sharp & Dohme70

Mitsubishi Tanabe Pharma 71

Novartis 71

Novo Nordisk 72

Pfizer 73

Roche 74

Sanofi 74

SciClone 75

Servier 76

Shionogi 76

Takeda 77

Local Manufacturers 78

2 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs